Capecitabine related impurities standards | SynZeal

Capecitabine is a Fluoropyrimidine Carbamate belonging to the class of Antineoplastic Agents called Antimetabolites. Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine was patented in 1992 and approved for medical use in 1998. It is on the World Health Organization's List of Essential Medicines.



SynZeal offers all Capecitabine related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Capecitabine related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.

Comments

Popular posts from this blog

The Crucial Role of Reference Standards in the Pharmaceutical Industry

The Crucial Role of Reference Standards in the Pharmaceutical Industry: Why SynZeal Sets the Benchmark

Pharmaceutical Reference Standards: A Complete Guide by SynZeal